Celiac Disease and Persistent Symptoms

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 1, 2011, Pages 13-17

  Rubio Tapia, Alberto ^a   Barton, Susan H ^a   Murray, Joseph A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CELIAC DISEASE; CONTINUING EDUCATION; DIFFERENTIAL DIAGNOSIS; GLUTEN FREE DIET; HUMAN; MALE; MEDICAL EDUCATION; SYMPTOMATOLOGY;

ADULT; CELIAC DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC;

EID: 78650237544     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.07.014     Document Type: Article

References (36)

1. Murray J.A., Watson T., Clearman B., et al. Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr 2004, 79:669-673.
2. Rostom A., Murray J.A., Kagnoff M.F. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006, 131:1981-2002.
3. Rubio-Tapia A., Rahim M.W., See J.A., et al. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 2010, 105:1412-1420.
4. Campanella J., Biagi F., Ilaria Bianchi P., et al. Clinical response to gluten withdrawal is not an indicator of coeliac disease. Scand J Gastroenterol 2008, 43:1311-1314.
5. Rubio-Tapia A., Van Dyke C.T., Lahr B.D., et al. Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol 2008, 6:983-987.
6. Koskinen O., Lindfors K., Collin P., et al. Intestinal transglutaminase 2 specific antibody deposits in non-responsive coeliac disease. Dig Liver Dis 2010, 42:692-697.
7. Farrell R.J., Kelly C.P. Celiac sprue. N Engl J Med 2002, 346:180-188.
8. Owens S.R., Greenson J.K. The pathology of malabsorption: current concepts. Histopathology 2007, 50:64-82.
9. Westergaard H. Tropical sprue. Curr Treat Options Gastroenterol 2004, 7:7-11.
10. Akram S., Murray J.A., Pardi D.S., et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol 2007, 5:1282-1290. quiz 1245.
11. Corazza G.R., Biagi F., Volta U., et al. Autoimmune enteropathy and villous atrophy in adults. Lancet 1997, 350:106-109.
12. Biagi F., Bianchi P.I., Trotta L., et al. Anti-goblet cell antibodies for the diagnosis of autoimmune enteropathy?. Am J Gastroenterol 2009, 104:3112.
13. Rubio-Tapia A., Talley N.J., Gurudu S.R., et al. Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol 2010, 8:344-349. e3.
14. Vakiani E., Arguelles-Grande C., Mansukhani M.M., et al. Collagenous sprue is not always associated with dismal outcomes: a clinicopathological study of 19 patients. Mod Pathol 2010, 23:12-26.
15. Pietzak M.M. Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology 2005, 128:S135-S141.
16. Rubio-Tapia A., Barton S.H., Rosenblatt J.E., et al. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol 2009, 43:157-161.
17. Leeds J.S., Hopper A.D., Hurlstone D.P., et al. Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms?. Aliment Pharmacol Ther 2007, 25:265-271.
18. Green P.H., Yang J., Cheng J., et al. An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol 2009, 7:1210-1216.
19. Pardi D.S. Microscopic colitis: an update. Inflamm Bowel Dis 2004, 10:860-870.
20. Abdulkarim A.S., Burgart L.J., See J., et al. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 2002, 97:2016-2021.
21. Rubio-Tapia A., Murray J.A. Classification and management of refractory coeliac disease. Gut 2010, 59:547-557.
22. Green P.H., Cellier C. Celiac disease. N Engl J Med 2007, 357:1731-1743.
23. Leffler D.A., Dennis M., Hyett B., et al. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 2007, 5:445-450.
24. Evans K.E., Sanders D.S. Joint BAPEN and British Society of Gastroenterology Symposium on "Coeliac disease: basics and controversies." Coeliac disease: optimising the management of patients with persisting symptoms?. Proc Nutr Soc 2009, 68:242-248.
25. Daum S., Cellier C., Mulder C.J. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 2005, 19:413-424.
26. Biagi F., Corazza G.R. Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol 2001, 13:561-565.
27. Cellier C., Delabesse E., Helmer C., et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000, 356:203-208.
28. Al-Toma A., Verbeek W.H., Hadithi M., et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 2007, 56:1373-1378.
29. Cellier C., Cerf-Bensussan N. Treatment of clonal refractory celiac disease or cryptic intraepithelial lymphoma: a long road from bench to bedside. Clin Gastroenterol Hepatol 2006, 4:1320-1321.
30. Brar P., Lee S., Lewis S., et al. Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol 2007, 102:2265-2269.
31. Rubio-Tapia A., Kelly D.G., Lahr B.D., et al. Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 2009, 136:99-107. quiz 352-353.
32. Malamut G., Afchain P., Verkarre V., et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009, 136:81-90.
33. Al-Toma A., Goerres M.S., Meijer J.W., et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol 2006, 4:1322-1327. quiz 1300.
34. Al-toma A., Visser O.J., van Roessel H.M., et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood 2007, 109:2243-2249.
35. Verbeek W.H., Goerres M.S., von Blomberg B.M., et al. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease. Clin Immunol 2008, 126:48-56.
36. Liu H., Brais R., Lavergne-Slove A., et al. Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease. Gut 2010, 59:452-460.